Conference Coverage

Personal omics profiling here to stay

Publish date: December 21, 2017

 

EXPERT ANALYSIS FROM WCIRDC 2017

He disclosed that he is a scientific adviser to Personalis, Genapsys, SensOmics, and Qbio.

dbrunk@frontlinemedcom.com

Pages

Recommended Reading

Which Is Junk: The Aspartame, or the Science?
Type 2 Diabetes ICYMI
Intranasal insulin, ketogenic diet may benefit Alzheimer’s patients
Type 2 Diabetes ICYMI
FDA approves injectable diabetes drug that improves A1c scores
Type 2 Diabetes ICYMI
Health disparities in rural America: Chronic conditions
Type 2 Diabetes ICYMI
Expert discusses the role of salt and fructose in diabetes
Type 2 Diabetes ICYMI
Shift to long-term ‘maternal care’ needs boost
Type 2 Diabetes ICYMI
Type 2 diabetes remitted with low-calorie diet
Type 2 Diabetes ICYMI
FDA approves first follow-on short-acting insulin product using abbreviated approval pathway
Type 2 Diabetes ICYMI
ADA guidelines embrace heart health
Type 2 Diabetes ICYMI
Link between glucose control and CVD risk: It’s complicated
Type 2 Diabetes ICYMI